Selectimmune Pharma AB publ announced earnings results for the fourth quarter ended June 30, 2021. For the fourth quarter, the company announced operating loss was SEK 5.063 million compared to SEK 1.128 million a year ago. Net loss was SEK 5.064 million compared to SEK 1.128 million a year ago. For the full year, operating loss was SEK 12.643 million compared to SEK 8.240 million a year ago. Net loss was SEK 12.643 million compared to SEK 8.240 million a year ago.